MRI-based biomarkers for ALS

18 May MRI-based biomarkers for ALS

The purpose of this study is to identify possible brain or spinal cord differences in participants with ALS compared to participants without ALS. Research shows that 90 to 95 percent of ALS cases occur at random, with only 5-10 percent of ALS cases being inherited. Current MRI techniques are only partly capable of recognizing the different types of ALS. And, early stages of ALS can be similar to other more treatable disorders. This study hopes to see if there are differences on MRIs that might allow earlier diagnosis and to recognize ALS subtypes.

*Please note: this study is located in Spokane, WA*

Participant Eligibility

• Between 18 and 80 years of age
• Have been clinically diagnosed with early stage Amyotrophic Lateral Sclerosis (ALS)

-or-

• Healthy control volunteer without ALS.

Contact

Lucas Sass
(208) 885-1578